阿托伐他汀 – 全港最多受訪醫生選用的膽固醇藥1

  • 參考資料PM-COR-22-112808

    1. Ipsos Healthcare 2020 Lipid Lowering Agent Preference Study Interviewed 200 HCPs (Cardiologists, Endocrinologists, Nephrologists, Neurologists and GP/IM/GOPC) in Hong Kong March – May 2020.
    2. About Atorvastatin. National Health Services. 2022. Available at: Accessed on February 14, 2023.
    3. Lipitor® (atorvastatin) Prescribing Information. Viatris Healthcare Hong Kong: Version November 2020.
    4. My cholesterol guide: Take action. Live Healthy! American Heart Association. Available at: Accessed on February 14, 2023.
    5. Lipitor® Core Claims Document (C-LIP-GLB-0387). Data on file.
    6. Cardiovascular disease: risk assessment and reduction, including lipid modification. Clinical guideline [CG181]. National Institute for Health and Care Excellence. 2014. Available at: Accessed on February 14, 2023.
    7. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/ NLA/PCNA Guideline on the management of blood cholesterol: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):e285-e350.
    8. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-188.